State Street SPDR SandP 400 Mid Cap Growth ETF (MDYG)
Live price chart, market sentiment, and community perspectives for State Street SPDR SandP 400 Mid Cap Growth ETF (AMEX: MDYG).
Live price chart, market sentiment, and community perspectives for State Street SPDR SandP 400 Mid Cap Growth ETF (AMEX: MDYG).
On our desk, we are seeing strong institutional interest following the recent 8.5% war-driven pullback in MDYG. Trading at roughly a 20x forward P/E, it offers a much cheaper alternative to stretched large-cap growth peers while retaining high earnings growth potential.
Watching the 50-day moving average near $108.50, technical indicators look encouraging as MDYG recently hit new 12-month highs around $111. The low expense ratio of 0.15% and $2.82B to $2.99B AUM make it an efficient core holding for capturing a mid-cap market recovery.
From a risk management standpoint, we must remain mindful that mid-sized companies inherently carry higher volatility than large-caps, even if they are less volatile than micro-caps. MDYG's beta of 1.05 means it tracks the broader market closely, exposing it quickly to any unexpected hawkish Fed pivots or macroeconomic shocks.
As a hedge fund portfolio manager, I appreciate the massive reduction in short interest we observed through June, where short shares plunged by over 52% down to 0.3% of total shares. With a days-to-cover ratio sitting at a minimal 0.7 days, short pressure is virtually non-existent here.
When analyzing execution protocols for quantitative rotation strategies, MDYG's average daily volume of roughly 90,000 to 93,000 shares provides ample liquidity for our basket creations and redemptions through Creation Unit Aggregations without introducing excessive slippage.
Looking closely at the underlying structure, MDYG operates as a diversified open-ended physical ETF tracking the SandP MidCap 400 Growth Index. However, investors must stay alert to capital gains tax considerations and the max short-term capital gains rate of 39.60% when managing tactical rebalancing.
Explore plasma cleansing, somatic organ swaps, and BCI.